The ECIU University, the European university of which the UAB is member, will receive 2 million euros in funding from the European Commission's Horizon 2020 programme, to strengthen theh research and innovation activities of the future SMART-ER (ECIU University Research Institute for SMART European Regions).
The UAB and CREAF research group Grumets has developed a Covid-19 maps navigator which allows analysing the current situation of the pandemic and discovering its evolution from the first case to the global, national and regional dimensions it now occupies. An open access navigator, it provides information on a multiple of variables, such as active cases, mortality and the latest news on its evolution.
A research team will create tools which rapidly detect vulnerability to post-traumatic stress among healthcare workers exposed to SARS-CoV 2. Another team will focus on guaranteeing that remote working does not reinforce gender inequalities. Both will receive funding from the Fondo Supera Covid-19.
The project, coordinated by the UAB, aims to improve recovering medicines from wastewater and has been chosen to participate in the online edition of Science is Wonderful, which forms part of the EU Research and Innovation Days.
AEInnova, a spin-off of the Department of Microelectronics, was awarded the prize in recognition of the technology it has developed, which allow capturing residual industrial heat and turning it into clean energy.
The nanoparticle targets only leukemic cells. The receptor for this nanoparticle is expressed in 20 types of cancer and associated with a poor prognosis, so this drug could open a new therapeutic pathway for other tumors.
The UAB and the UAB Research Park will be offering COViDeació training workshops on 22 and 23 July with the aim of generating and validating research and innovation solutions to the social challenges posed by COVID-19.
Researchers from the IBB-UAB will collaborate with Servier to find new molecules capable of blocking the alpha-synucleic protein, the accumulation of which is the main factor causing Parkinson's disease.
Researchers from the UAB Institute of Biomedicine and Biotechnology, the ICN2 and the Vall d’Hebron Research Institute (VHIR) received a grant from the BBVA Foundation to develop their NANO-ERT project.